In Silico Insight the Prediction of Chlorogenic Acid in Coffee through Cyclooxygenase-2 (COX2) Interaction

  • Yohanes Bare Nusa Nipa University
    (ID)
  • Dewi Ratih Tirto Sari Brawijaya University
    (ID)
  • Yoga Tribakti Rachmad Sekolah Progresif Bumi Shalawat
    (ID)
  • Gabriella Candrakirana Krisnamurti King Mongkut’s University of Technology Thonburi
    (TH)
  • Agustina Elizabeth Nusa Nipa University
    (ID)
  • Andri Maulidi Palangka Raya University

Abstract

Inflammation was signs of pathological or abnormality in tissue to give an alert as a trouble signal to the system. Therapeutic using NSAIDs has some side effects. This research explored the potential role of chlorogenic acid as natural therapeutic compound to inhibit the inflammation target such as COX-2 by interaction model. The research method used in this study was the molecular docking approach, which binds ligand and protein. Protein data provided by Protein Data Bank (ID: 6cox) while, chlorogenic acid obtain from PubChem (CID: 1794427). We docked COX-2 and chlorogenic acid using Hex 8.0.0. Visualization and analysis of the molecular interactions of chlorogenic acid and COX-2 conducted by the Discovery Studio Client 4.1 software. Chlorogenic acid has a high permeability and is easily absorbed based on five Lipinski Rule. Interestingly, we found Fifteen amino acid was binding with chlorogenic acid that formed by hydrogen bond and van der Waals.The interaction between ligand-protein results in energy binding -327.59cal/mol. Chlorogenic acid has a potential role to inhibit inflammation pathway by inhibiting COX-2. We predicted chlorogenic acid has a potential as therapy anti-inflammatory to suppress COX-2 as mediator inflammation.

Author Biographies

Yohanes Bare, Nusa Nipa University
Biology Education Program Study, Faculty of Teaching and Training
Dewi Ratih Tirto Sari, Brawijaya University

Biology Department, Faculty of Mathematics and Natural science, Brawijaya University

Yoga Tribakti Rachmad, Sekolah Progresif Bumi Shalawat

Research Group of Sekolah Progresif Bumi Shalawat

Gabriella Candrakirana Krisnamurti, King Mongkut’s University of Technology Thonburi
Biotechnology Program, School of Bioresources and Technology, King Mongkut’s University of Technology Thonburi
Agustina Elizabeth, Nusa Nipa University

Physics Education Study Program, Faculty of Teaching and Training, Nusa Nipa University

References

Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. 2018. The crucial roles of inflammatory mediators in inflammation: a review. Vet World. vol 11: 627–635. https://doi.org/10.14202/vetworld.2018.627-635.

Al-Saeed A. 2011. Gastrointestinal and cardiovascular risk of nonsteroidalanti-inflammatory drugs. Oman Medical Journal. 26, 385–391. doi: https://doi.org/10.5001/omj.2011.101.

Bäck M, Yin L, Ingelsson E. 2012. Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib. European Heart Journal. vol 33(15): 1928–1933. https://doi.org/10.1093/eurheartj/ehr421.

Bare Y, Krisnamurti GC, Elizabeth A, Rachmad YT, Sari DRT, Lorenza MRWG. 2019a. The potential role of caffeic acid in coffee as cyclooxygenase-2 (COX-2) inhibitor: in silico study. Biointerface Research Applied Chemistry. vol 9(5): 4424–4427. doi: https://doi.org/10.33263/BRIAC95.424427.

Bare Y, Marhendra A, Sasase T, Fatchiyah F. 2018. Differential expression of IL-10 gene and protein in target tissues of Rattus norvegicus strain wistar model type 2 diabetes mellitus (T2DM). Acta Informatica Medica. vol 26(2): 87–92. doi: https://doi.org/10.5455/aim.2018.26.87-92.

Bare Y, Sari DRT, Rachmad YT, Sulistyaningsih S, Tiring ND, Rophi AH, Nugraha FAD. 2019b. Prediction potential chlorogenic acid as inhibitor ace (in silico study). Bioscience. vol 3(2): 197–203. doi: https://doi.org/10.24036/0201932105856-0-00.

Buchanan FG, Wang D, Bargiacchi F, DuBois RN. 2003. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. Journal Biological Chemistry. vol 278(3): 35451–35457. doi: https://doi.org/10.1074/jbc.M302474200.

Farah A, Monteiro M, Donangelo CM, Lafay S. 2008. Chlorogenic acids from green coffee extract are highly bioavailable in humans. The Journal of Nutrition. vol 138(12): 2309–2315. doi: https://doi.org/10.3945/jn.108.095554.

Knights KM, Mangoni AA, Miners JO. 2010. Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity. Expert Revie Clinical Pharmacology. vol 3(6): 769–776. doi: https://doi.org/10.1586/ecp.10.120.

Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC., 1996. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. vol 384(6610): 644–648. doi: https://doi.org/10.1038/384644a0.

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews. vol 46(1-3): 3–26. doi: https://doi.org/10.1016/S0169-409X(96)00423-1.

Moon JK, Yoo HS, Shibamoto T. 2009. Role of roasting conditions in the level of chlorogenic acid content in coffee beans: correlation with coffee acidity. Journal of agricultural and food chemistry. vol 57(12): 5365–5369. doi: https://doi.org/10.1021/jf900012b.

Perez YR, Alvarez D, Combariza A. 2019. Ligand-Protein Interactions: A Hybrid ab initio/Molecular Mechanics Computational Study. Preprints. vol 1(2019): 1–24. doi: https://doi.org/10.20944/preprints201902.0124.v1.

Phalitakul S, Okada M, Hara Y, Yamawaki H. 2011. Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. Pharmacological Research. vol 64(5): 493–500. doi: https://doi.org/10.1016/j.phrs.2011.06.001.

Poligone B, and Baldwin AS. 2001. Positive and negative regulation of NF-κB by COX-2: roles of different prostaglandins. The Journal of Biological Chemistry. vol 276(42): 38658–38664. doi: https://doi.org/10.1074/jbc.M106599200.

Pop-Busui R, Kellogg A, Cheng H. 2008. Cyclooxygenase-2 Pathway as a Potential Therapeutic Target in Diabetic Peripheral Neuropathy. Current Drug Targets. vol 9(1): 68–76. doi: https://doi.org/10.2174/138945008783431691.

Rachmad, Y.T., Wihastuti, T.A., Miyajima, K., Fatchiyah, F., 2018. Activity of caprine CSN1S2 protein reducing the COX-2 and IL-17 expression of aorta tissue in type 2 diabetes mellitus rat. Journal of Mathematical and Fundamental Sciences. vol 50(3): 332–345. doi: https://doi.org/10.5614/j.math.fund.sci.2018.50.3.8.

Santoso B, Atmajaya TE, Tirtodiharjo MK. 2016. Kajian docking senyawa 4-[(Z)-N-(4-hidroksifenil) carboksimidoil]-2- metoksifenol sebagai inhibitor Cox-2 menggunakan plants. Prosiding Seminar Nasional Kimia UNJANI-HKI. 3-4 Agustus 2016. Bandung: Universitas Jenderal Achmad Yani. ISBN 978-602-60732-0-4. pp. 270–275.

Shi H, Dong L, Jiang J, Zhao J, Zhao G, Dang X, Lu X, Jia M. 2013. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology. vol 303: 107–114. doi: https://doi.org/10.1016/j.tox.2012.10.025.

Smith WL, and Murphy RC. 2016. The Eicosanoids: Cyclooxygenase, Lipoxygenase and Epoxygenase Pathways in: Biochemistry of Lipids, Lipoproteins and Membranes. Amsterdam: Elsevier. pp. 259–296. doi: https://doi.org/10.1016/B978-0-444-63438-2.00009-2.

Watanabe T, Arai Y, Mitsui Y, Kusaura T, Okawa W, Kajihara Y, Saito I. 2006. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clinical and experimental hypertension. vol 28(5): 439–449. doi: https://doi.org/10.1080/10641960600798655.

Xu L, Stevens J, Hilton MB, Seaman S, Conrads TP, Veenstra TD, Logsdon D, Morris H, Swing DA, Patel NL, Kalen J, Haines DC, Zudaire E, St. Croix B. 2014. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Science Translational Medicine. vol 6(242): 242ra84–242ra84. doi: https://doi.org/10.1126/scitranslmed.3008455.

Published
2019-12-29
Section
Research Articles
Abstract viewed = 867 times

Most read articles by the same author(s)